Akèy › Kansè pwostat › Arizona › Tucson
Etid klinik pou Kansè pwostat nan Tucson, AZ
11 etid pou Kansè pwostat ap chèche patisipan nan sit nan ak bò kote Tucson (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Ap rekriteFaz 3
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Ap rekriteFaz 2
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Ap rekriteFaz 3
- The University of Arizona Cancer Center - North Campus ( Site 0073), Tucson
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Ap rekriteFaz 3
- University of Arizona Cancer Center, Tucson
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Ap rekriteFaz 2
- The University of Arizona Cancer Center - North Campus, Tucson
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Arizona Cancer Center at University of Arizona, Tucson
Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
Ap rekriteFaz 1
- Arizona Urology Specialists, Tucson
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Ap rekriteFaz 1
- The University of Arizona Cancer Center, Tucson
4-aminopyridine Treatment for Nerve Injury
Ap rekriteFaz 2/3
- University of Arizona, Tucson
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Research Site 111, Tucson
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Ap rekriteFaz 3
- University of Arizona Cancer Center-Orange Grove Campus, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
Etid Kansè pwostat nan lòt vil
- New York City, NY103 etid
- Houston, TX76 etid
- Los Angeles, CA61 etid
- Boston, MA59 etid
- St. Louis, MO46 etid
- Chicago, IL45 etid
- San Francisco, CA45 etid
- Philadelphia, PA44 etid
- Baltimore, MD43 etid
- Nashville, TN42 etid
- Seattle, WA42 etid
- Washington, DC38 etid
Lòt etid nan Tucson
- Kansè nan tete20 etid
- Kansè Poumon ki pa ti selil17 etid
- Obèsite17 etid
- Sipwa15 etid
- Kansè Metastatik14 etid
- Kansè (tout kalite)12 etid
- Maladi kadyovaskilè12 etid
- Kansè kolorektal11 etid
- Maladi fwa steatotik10 etid
- Ensifizyans kadyak10 etid
- Hypertension artérielle10 etid
- Dyabèt Tip 210 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.